Return to search results
Acitretin
Acitretin is a generic prescription drug, available as oral capsules in strengths of 10mg, 17.5mg, 22.5mg, and 25mg. It belongs to the retinoid class and is used to treat severe forms of psoriasis that don't respond to other therapies. Manufactured by Amneal Pharmaceuticals of New York LLC under application ANDA202552. This information was generated using AI and is provided for informational and research purposes only.
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Acitretin is a generic prescription drug, available as oral capsules in strengths of 10mg, 17.5mg, 22.5mg, and 25mg. It belongs to the retinoid class and is used to treat severe forms of psoriasis that don't respond to other therapies. Manufactured by Amneal Pharmaceuticals of New York LLC under application ANDA202552. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Acitretin",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Acitretin — ANDA 091455 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=091455"
}
]
|
| identifier | ANDA091455 |
| issued | 2016-09-16 |
| keyword |
[
"drug-safety",
"fda",
"health-care",
"pharmaceuticals",
"public-health"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Acitretin |
